Hintergrundwissen – Radiologische Untersuchung der Brust (Kap. 13)

l Leitfaden l Glossar l Inhalt Hintergrundwissen l

13. Literatur

1. Statistik Austria, Mitteilung vom 17.10.2003
2. Vutuc C, Haidinger G. Epidemiologie und Prävention von Brustkrebs. Wien Med Wochenschr. 2000;150:54-7
3. Jakesz R, Samonigg H, Gnant M et al. Significant increase in breast conservation in 16 years of trials conducted by the Austrian Breast & Colorectal Cancer Study Group. Ann Surg. 2003 Apr;237(4):556-64.
4. Veronesi U, Cascinelli N, Mariani L et al. Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast Cancer. N Engl J Med 2002; 347:1227-1232.
5. Vutuc C, Waldhoer T., Klimont J.  et al. Entwicklung der Überlebensraten von Brustkrebspatientinnen in Österreich nach Alter, Tumorstadium und Diagnosezeitraum. Wien Klein Wochenschr. 2002;114:438-442
6. Vutuc C, Haidinger G, Waldhoer T. Prevalence of self-reported screening mammography and impact on breast cancer mortality in Austria. Wien Klein Wochenschr 1998;110:485-490
7. Ernst MF, Voogd AC, Coebergh JW et al. Breast carcinoma diagnosis, treatment, and prognosis before and after the introduction of mass mammographic screening. Cancer 2004;100(7):1337-44.
8. Perdue P, Page D, Nellestein M et al. Early detection of breast carcinoma: a comparison of palpable and nonpalpable lesions. Surgery 1992;111(6):656-9
9. Segura JM, Castells X, Casamitjana M, Macia F, Ferrer F. Utilization of screening mammography as a preventive practice prior to initiating a population-based breast cancer screening program. J Clin Epidemiol. 2000;53(6):595-603.
10. James JJ, Evans AJ, Pinder SE, Macmillan RD, Wilson AR, Ellis IO. Is the presence of mammographic comedo calcification really a prognostic factor for small screen-detected invasive breast cancers? Clin Radiol. 2003;58(1):54-62.
11. Schneider C, Fehr MK, Steiner RA, Hagen D, Haller U, Fink D. Frequency and distribution pattern of distant metastases in breast cancer patients at the time of primary presentation. Arch Gynecol Obstet. 2003;269(1):9-12.
12. Evans AJ, Pinder SE, Burrel HC et al. Detecting which invasive cancers at mammographic screening saves lives? J Med Screen 2001;8:86-90
13. Freedman GM, Anderson PR, Goldstein LJ et al. Routine mammography is associated with earlier stage disease and greater eligibility for breast conservation in breast carcinoma patients age 40 years and older. Cancer. 2003;98(5):918-25.
14. Michaelson JS, Satija S, Kopans D, Moore R, Silverstein M, Comegno A, Hughes K, Taghian A, Powell S, Smith B. Gauging the impact of breast carcinoma screening in terms of tumor size and death rate. Cancer 2003;98:2112-2124.
15. Roger V, Beito G, Jolly PC. Factors affecting the incidence of lymph node metastases in small cancers of the breast. Am J Surg 1989;157:501–502.
16. Silverstein MJ, Gierson ED, Waisman JR, et al. Axillary lymph node dissection for T1a breast carcinoma. Cancer 1994;73:664–667.
17. Rosen PP, Groshen S: Factors influencing survival and prognosis in early breast carcinoma (T1N0M0-T1N1M0). Assessment of 664 patients with median follow-up of 19 years. Surg Clin North Am 1990;70:937–962.
18. Osborne CK: Prognostic factors in breast cancer. Princ Pract Oncol 1990;4: 1–11.
19. Zonderland HM, Coerkamp EG, Hermans J, van de Vijver MJ, van Voorthuisen AE. Diagnosis of breast cancer: contribution of ultrasound as an adjunct to mammography. Radiology 1999;213:413-422.
20. Cilotti A, Bagnolesi P, Moretti M et al: Comparison of the diagnostic performance of high-frequency ultrasound as a first- or second-line diagnostic tool in non-palpable lesions of the breast. Eu Radiol 1997;7:1240-1244.
21. Leconte I, Feger C, Galant C et al. Mammography and subsequent whole-breast sonography of nonpalpable breast cancers: the importance of radiologic breast density. Am J Roentgenol 2003;180:1675-1679.
22. Teh W, Wilson AR. The role of ultrasound in breast cancer screening. A consensus statement by the European Group for Breast Cancer Screening. Eur J Canc 1998;34:449-450.
23. Houssami N, Irwig L, Loy C. Accuracy of combined imaging in young women. Breast 2002;11:36-40.
24. Kouskos E, Markopoulos C, Mantas D, Revenas K, Antonopoulou Z, Kontzoglou K, Gogas J. Missed cancers on mammograms: causes and measures of prevention. Eur J Gynaecol Oncol. 2004;25(2):230-2.
25. Majid AS, de Paredes ES, Doherty RD, Sharma NR, Salvador X. Missed breast carcinoma: pitfalls and pearls. Radiographics 2003;23(4):881-95
26. Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet. 2000 Jan 8;355(9198):129-34.
27. Olsen O, Gotzsche PC. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2001;(4):CD001877
28. Olsen O, Gotzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet. 2001 20;358(9290):1340-2
29. Feig SA, D´Orsi CJ, Hendrick RE, et al. American College of Radiology Guidelines for breast cancer screening. Am J Roentgenol 1998;171:29-33
30. Houssami N, Irwig L, Simpson JM, McKessar M, Blome S, Noakes J. The contribution of work-up or additional views to the accuracy of diagnostic mammography. Breast 2003;12:270-275.
31. Ärztliche Konzertierte Aktion zur Brustkrebs-Früherkennung, Z.ärztl. Fortbild. Qualitätssicherung 2000;94:421-422
32. Ciatto S, Visioli C, Paci E, Zappa M. Breast density as a determinant of interval cancer at mammographic screening. Br J Cancer. 2004;90:393-396.
33. Roubidoux MA, Bailey JE, Wray LA, Helvie MA. Invasive cancers detected after breast cancer screening yielded a negative result: relationship of mammographic density to tumor prognostic factors. Radiology 2004;230:42-48.
34. Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination and breast US and evaluation of factors that influence them: an analysis of 27.825 patient evaluations. Radiology 2002;225:165-175
35. Van Gils CH, Otten JDM, Verbeek ALM, Hendriks JH. Mammographic breast density and risk of breast cancer: masking bias or causality? Eur J Epidemiol 1998;14:315-320.
36. White E, Velentgas P, Mandelson MT et al. Variation in mammographic breast densitiy by time in menstrual cycle among women aged 40-49 years. J Natl Cancer Inst. 1998;90:906-910
37. Stomper PC, Margolin FR. Ductal carcinoma in situ: The mammographer´s perspective. AJR 1994;162:585-591
38. Schnitt SJ, Silen W, Sadowsky NL et al. Ductal carcinoma in situ (intraductal carcinoma) of the breast. N Engl J Med 1988;318:898-903
39. Morris EA, Liberman L, Ballon DJ, Robson M, Abramson AF, Heerdt A, Dershaw DDE. MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol 2003;181:619-626.
40. Beyer T, Moonka R. Normal mammography and ultrasonography in the setting of palpable breast cancer. Am J Surg. 2003;185(5):416-9.
41. Shetty MK, Shah YP, Sharman RS. Prospective evaluation of the value of combined mammographic and sonographic assessment in patients with palpable abnormalities of the breast. J Ultrasound Med. 2003;22:263-8
42. Kleit AN, Ruiz JF. False positive mammograms and detection controlled estimation.. Health Serv Res. 2003;38:1207-1228.
43. Tabar L, Dean PB, Pentek Z. Galactography: the diagnostic procedure of choice for nipple discharge. Radiology 1983;149(1):31-8.
44. Funovics MA, Philipp MO, Lackner B et al. Galactography: method of choice in pathologic nipple discharge? Eur Radiol. 2003;13(1):94-9.
45. Ciatto S, Roselli del Turco M, Catarzis M et al. The diagnostic role of breast echography. Radiol Med 1994;88:221
46. Jackson VP. The role of US in breast imaging. Radiology 1990;177:305
47. Yang WT, Tse GM. Sonographic, mammographic, and histopathologic correlation of symptomatic ductal carcinoma in situ. AJR Am J Roentgenol. 2004;182(1):101-10
48. Perry N.M. Position paper of the European Society of Mastology: Quality assurance in the diagnosis of breast disease. Eur J Cancer 2001;37:159-172
49. Gordon PB, Gagnon FA, Lanzowsky L. Solid breast masses diagnosed as fibroadenoma at fine-needle aspiration biopsy: acceptable rates of growth at long term follow-up. Radiology 2003;229:233-238.
50. Heywang-Köbrunner SH, Schreer I. Bildgebende Mammadiagnostik. Georg Thieme Verlag, 2. Auflage 2003.
51. Chen WM, Chang RF, Moon WK, Chen DR. Breast cancer diagnosis using three-dimensional ultrasound and pixel relation analysis. Ultrasound Med Biol 2003;29:1027-1035.
52. Tamimi SO, Ahmed A. Stromal changes in invasive breast carcinoma: an ultrastructural study. J Pathol 1987;153:163-170. 
53. Winnekendonk G, Krug B, Warm M, Gohring UJ, Mallmann P, Lackner K. Diagnostischer Stellenwert der präoperativen MR-Mammographie. Röfo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr. 2004;176(5):688-93.
54. Wurdinger S, Kamprath S, Eschrich D, Schneider A, Kaiser WA. False negative findings of malignant breast lesions on preoperative magnetic resonance mammography. Breast 2001;10:131-139.
55. Kuhl CK, Bieling HB, Gieseke J, Kreft BP, Sommer T, Lutterbey G, Schild HH. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology. 1997;203(1):137-44.
56. Müller-Schimpfle M, Ohmenhäuser K, Stoll P et al. Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology 1997;203:145-149.
57. Morgan DE, Kenney PJ, Meeks MC et al. MR imaging of breast implants and their complications. AJR Am J Roentgenol 1996;167(5):1271-5.
58. Kuhl CK, Schmutzler RK, Leutner CC et al.  Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 2000;215:267-279.
59. Kramer SC, Rieber A, Gorich J et al. Diagnosis of papillomas of the breast: value of magnetic resonance mammography in comparison with galactography. Eur Radiol 2000;10(11):1733-6.
60. Morakkabati N, Leutner CC, Schmiedel A et al. Breast MR imaging during or soon after radiation therapy. Radiology 2003;229(3):893-901.
61. Van Goethem M, Schelfout K, Dijckmans L, Van Der Auwera JC, Weyler J, Verslegers I, Biltjes I, De Schepper A. MR mammography in the pre-operative staging of breast cancer in patients with dense breast tissue: comparison with mammography and ultasound. Eur Radiol. 2004;14(5):809-817
62. Fuchsjager MH, Helbich TH, Pfarl G et al. Electrical impedance scanning in the differentiation of suspicious breast lesions: comparison with mammography, ultrasound and histopathology Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2002;174(12):1522-9.
63. Flöry D, Riedl CC, Matzek W et al. Computed Tomography Laser Mammography (CTLM): Morphologische Kriterien Maligner Brusttumore Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2004;176:S217.
64. Van Houten EE, Doyley MM, Kennedy FE et al. Initial in vivo experience with steady-state subzone-based MR elastography of the human breast. J Magn Reson Imaging 2003;17(1):72-85.
65. McLelland R, Hendrick RE, Zinninger MD et al.: The American College of Radiology Mammography Accreditation Program. AJR AM J Roentgenol 1991;157:473-9.
66. Pfarl G, Helbich TH.Breast Imaging Reporting and Data System (BI-RADS)--German version Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2002;174(7):921-6.
67. Collins LC, Connolly JL, Page DL, Goulart RA, Pisano ED, Fajardo LL, Berg WA, Caudry DJ, McNeil BJ, Schnitt SJ. Diagnostic agreement in the evaluation of image-guided breast core needle biopsies: results from a randomized clinical trial. Am J Surg Pathol. 2004 Jan;28(1):126-31.
68. Kettritz U, Rotter K, Schreer I, Murauer M, Schulz-Wendtland R, Peter D. Stereotactic vacuum-assisted breast biopsy in 2874 patients: a multicenter study. Cancer. 2004 Jan 15;100(2):245-51.
69. Pfarl G, Helbich TH, Riedl CC et al. Stereotactic 11-gauge vacuum-assisted breast biopsy: a validation study. AJR Am J Roentgenol 2002;179(6):1503-7.
70. Pfarl G, Helbich TH, Riedl CC et al.Stereotactic needle breast biopsy: Diagnostic reliability of various biopsy systems and needle sizes Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2002;174(5):614-9.
71. Helbich T. Konsensuspapier: Stereotaktisch und ultraschallgezielte Vakuumbiopsie von Brustläsionen JATROS 2002;1:10-15  (www.oerg.at)
72. Memarsadeghi M, Pfarl G, Riedl CC et al. Value of 14-gauge ultrasound-guided large-core needle biopsy of breast lesions: own results in comparison with the literature. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2003;175(3):374-80.
73. Grant GS, Goellner JR, Welch JS, Martin JK: Fine-needle aspiration of the breast. Mayo Clin Proc 1986;61:377-381.
74. Riedl CC, Pfarl G, Helbich TH et al. Comparison of wire versus carbon localization of non-palpable breast lesions. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2002;174(9):1126-31.)
75. Liberman L, Evans WP 3rd, Dershaw DD, Hann LE, Deutch BM, Abramson AF, Rosen PP: Radiography of microcalcifications in stereotaxic mammary core biopsy specimens. Radiology 1994;190(1):223-5.
76. Perry N, Broeders M, de Wolf C, Tomberg S, eds. European Guidelines for Quality Assurance in Mammography Screening. European Commission Publication 3rd edition 2001.
77. Perry N.M. Position paper of the European Society of Mastology: The requirements of a specialist breast unit. Eur J Cancer 2000;36:2288-2293.
78. Sickles EA, Wolverton DE, Dee KE. Performance parameters for screening and diagnostic mammography: specialist and general radiologists. Radiology 2002;224:861-869.
79. Kan L, Olivotto IA, Warren Burhenne LJ, Sickles EA, Coldman AJ. Standardized abnormal interpretation and cancer detection ratios to assess reading volume and reader performance in a breast screening program. Radiology 2000;215:563-567.
80. Elmore JG, Wells CK, Howard DH. Does diagnostic accuracy in mammography depend on radiologists´ experience? J Womens Health 1998;7:443-449.
81. Schmidt F, Hartwagner KA, Spork EB, Gröll R. Medical audit after 26,711 breast imaging studies: improved rate of detection of small breast carcinomas (classified as Tis or T1a,b). Cancer 1998;83:2516-2520.
82. U.S. Department of Health and Human Services: Small entity compliance guide and overview of the final regulations implementing the Mammography Quality Standards Act. 1997:16-19
83. National Health Services Breast Screening Programme. Quality assurance guidelines for radiologists. The Royal College of Radiologists. Oxford, United Kingdom, 1990.
84. Ciccone G, Vineis P, Frigerio A, Segnan N. Inter-observer and intra-observer variability of mammogram interpretation: a field study. Eur J Cancer 1992;28A:1054-1058.
85. Harvey SC, Geller B, Oppenheimer RG, Pinedt M, Riddell L, Garra B. Increase in cancer detection and recall rates with independent double interpretation of screening mammography. Am J Roentgenol 2003;180:1461-1467.

    Autor: Prim. Dr. Hans Mosser, Vorstand des Inst. für Radiologie des Landesklinikums Krems

86. Anttinen I, Pamilo M, Soiva M, Roiha M. Double reading of mammography screening films - one radiologist or two? Clin Radiol. 1993;48(6):414-21.
87. Beam CA, Sullivan DC, Layde PM. Effect of human variability on independent double reading in screening mammography. Acad Radiol 1996;3:891-897 
88. Roohan Pj, Bickell NA, Baptiste MS, Therriault GD, Ferrara EP, Siu AL. Hospital volume differences and five-year survival from breast cancer. Am J Public Health 1998;88:454-457.

Autor: Prim. Dr. Hans Mosser, Vorstand des Inst. für Radiologie des Landesklinikums Krems

 

[vorheriges Kapitel] :: [Inhaltsverzeichnis]

 

Europa Donna Österreich - Netzwerk Brustkrebs
Kontakt: Ingrid Schnabl, Koordinatorin, Tel.: +43/650/902 32 65
E-Mail: ingrid.schnabl@europadonna.at

Europa Donna - die europäische Föderation gegen Brustkrebs - ist in 37 europäischen Staaten vertreten. http://www.europadonna.at
Spendenkonto: BA-CA, BLZ 12000, Konto-Nr.: 405 115 106